相关实验视频
Updated: Jan 16, 2026
08:04
Analyzing Platelet Subpopulations by Multi-color Flow Cytometry
Published on: June 10, 2025
1.4K
免疫性血小板缩中的血小板功能障碍:寻找具有血小板表型的临床子集
Sidra A Ali1, Sarah M Hicks1, Lucy A Coupland2,3
1Division of Genome Science and Cancer, John Curtin School of Medical Research, Australian National University, Canberra, Australian Capital Territory, Australia.
British journal of haematology
|September 29, 2025
概括
血小板功能测试可以帮助预测免疫血小板缺血 (ITP) 的出血风险. 测量血小板指数可以改善出血预测模型,而不仅仅是ITP患者的血小板数量.
科学领域:
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
- 临床诊断 临床诊断 临床诊断
背景情况:
- 免疫性血小板缺血 (ITP) 存在诊断和管理方面的挑战,特别是在预测出血风险方面.
- 综合性血小板功能评估对于有效的ITP临床管理至关重要.
研究的目的:
- 评估各种血小板参数,以预测免疫血小板缺血 (ITP) 患者的出血情况.
- 评估血小板指数在增强ITP出血风险预测模型中的有用性.
主要方法:
- 使用流细胞计量量化血小板表面蛋白质,网状血小板和激活.
- ELISA测量了可溶性受体碎片,素化基因组-DNA (CitH3-DNA) 复合体和血栓形成素 (TPO).
- 粘性弹性扫描评估了全血凝结和血小板对凝块形成的贡献.
主要成果:
- 患有出血症状的ITP患者显示糖蛋白 (GP) VI,Trem-like转录-1 (TLT-1),血小板结合免疫球蛋白 (Ig) G,CitH3-DNA复合体和TPO水平升高.
- 在有症状的ITP患者中观察到血小板对凝块形成的贡献减少.
- 多变量分析表明,与单独的血小板计数相比,血小板指数显著改善了出血预测 (78.1%对70.48%).
结论:
- 症状ITP患者表现出可测量的血小板功能障碍,表面异常,增加NETosis和TPO水平升高.
- 识别特定的生物标志物可以帮助定义临床相关的ITP疾病子集.
- 血小板功能评估为管理ITP和预测出血并发症提供了宝贵的见解.
相关概念视频
01:18Structure and Function of Platelets
3.0K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
3.0K
01:24Disorders of Hemostasis
2.0K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.0K
01:22Formation of the Platelet Plug
8.7K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
8.7K
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
1.1K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.1K